Routine SEBI compliance certificate on dematerialisation for Q2 FY27
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 1.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Suraksha Diagnostic has submitted a certificate from its Registrar KFin Technologies under SEBI Regulation 74(5) for the quarter ended 30 September 2026. It confirms that details of shares dematerialised and rematerialised during the quarter have been reported to BSE and NSE. The filing is procedural and carries no business update.
Routine compliance filing, no effect on operations, financials, or share price.